In our study of plasma levels of circulating immune markers and subsequent risk of BCL and main histological subtypes, growth factors and in particular, FGF‐2, TGF‐α and VEGF were found consistently associated (inversely) with incidence of MM. This evidence concerns the gene VEGFA and Miyoshi myopathy.